🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Determine whether viagenpumatucel-L combined with low-dose cyclophosphamide...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2014-07
Trial ID
NCT02117024
RATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor grow...
Status
Completed
Location
Children's Hospital Los Angeles
Start Date
2009-12
Trial ID
NCT00885326
Treatments Being Tested
Antibody-dependent cell-mediated cytotoxicity (ADCC) is one of the importan...
Status
Unknown
Location
Shusen Wang
Start Date
2021-06-25
Trial ID
NCT04941885
Treatments Being Tested
This multi-center, open-label, phase II randomized controlled trial is to e...
Status
Suspended
Location
Sun Yat-sen Memorial Hospital
Start Date
2016-09
Trial ID
NCT02897050
Based on data supporting the use of cyclophosphamide and etoposide both as ...
Status
Completed
Location
Central Jersey Oncology Center
Start Date
2005-05
Trial ID
NCT00176605
Treatments Being Tested
The purpose of this research study is to determine the safety and tolerabil...
Status
Completed
Location
Dana-Farber Cancer Institute
Start Date
2007-07
Trial ID
NCT00496665
Treatments Being Tested
This study will evaluate efficacy and safety of anti-PD-1/PD-L1 antibodies ...
Status
Recruiting
Location
EuroCityClinic LLC
Start Date
2025-08-14
Trial ID
NCT07130032
Treatments Being Tested
This study investigates the activity of a new regimen of treatment for pati...
Status
Completed
Location
Gastrointestinal Oncology Unit, Institute of Oncology, Davidoff Center, Rabin Medical Center, Belinson Campus,
Start Date
2015-01
Trial ID
NCT02280694
Treatments Being Tested
This is a Phase II single center, open-label, non-randomized study in patie...
Status
Recruiting
Location
Istituto Europeo di Oncologia
Start Date
2020-05-20
Trial ID
NCT03971045
Treatments Being Tested
The purpose of this study is to evaluate the safety and feasibility of long...
Status
Active Not Recruiting
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Start Date
2010-04-20
Trial ID
NCT01088789
Treatments Being Tested